[1]杨文韬 李芳萍 肖辉盛 程桦 郑东辉.一例以眼眶假瘤及垂体炎为首发的IgG4相关性疾病诊治 及随访[J].国际内分泌代谢杂志,2018,38(05):357-360.[doi:10.3760/cma.j.issn.1673-4157.2018.05.019]
　Yang Wentao*,Li Fangping,Xiao Huisheng,et al.The diagnosis, treatment and following up of a case of IgG4-related disease with the primary symptoms of ophthalmopathy and hypophysitis[J].International Journal of Endocrinology and Metabolism,2018,38(05):357-360.[doi:10.3760/cma.j.issn.1673-4157.2018.05.019]

点击复制

一例以眼眶假瘤及垂体炎为首发的IgG4相关性疾病诊治 及随访()

分享到：

参考文献/References:

[1] Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011. Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan[J]. Nihon Naika Gakkai Zasshi, 2012,101(3):795-804.
[2] Hufnagel M,Henneke P,Schmitt-Graeff A.IgG4-related disease[J].N Engl J Med,2012,366(17):1643-1644.DOI:10.1056/NEJMc1202768.
[3] Khosroshahi A,Wallace ZS,Crowe JL,et al.International consensus guidance statement on the management and treatment of IgG4-related disease[J].Arthritis Rheumatol,2015,67(7):1688-1699.DOI:10.1002/art.39132.
[4] Tabata T,Kamisawa T,Takuma K,et al.Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease[J].Intern Med,2011,50(2):69-75.
[5] Deshpande V,Zen Y,Chan JK,et al.Consensus statement on the pathology of IgG4-related disease[J].Mod Pathol,2012,25(9):1181-1192.DOI:10.1038/modpathol.2012.72.
[6] Kamisawa T,Zen Y,Pillai S,et al.IgG4-related disease[J].Lancet,2015,385(9976):1460-1471.DOI:10.1016/S0140-6736(14)60720-0.
[7] 茂幸,川野充弘. IgG4 相关性疾病解读//高比良雅之,安淳.眼科病变[M].1st ed.北京:人民军医出版社,2014,43-52.
[8] Shikuma J,Kan K,Ito R,et al.Critical review of IgG4-related hypophysitis[J].Pituitary,2017,20(2):282-291.DOI:10.1007/s11102-016-0773-7.
[9] 张盼盼,赵继志,王木,等.IgG4相关性疾病346例临床特征分析[J].中华内科杂志,2017,56(9):644-649.DOI:10.3760/cma.j.issn.0578-1426.2017.09.005.
[10] Bernreuther C,Illies C,Flitsch J,et al.IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis[J].Brain Pathol,2017,27(6):839-845.DOI:10.1111/bpa.12459.
[11] Allix I,Rohmer V.Hypophysitis in 2014[J].Ann Endocrinol(Paris),2015,76(5):585-594.DOI:10.1016/j.ando.2015.08.003.
[12] 季兰岚,张卓莉.IgG4相关疾病诊断及治疗的国际专家共识[J].中华风湿病学杂志,2016,20(8):576.DOI:10.3760/cma.j.issn.1007-7480.2016.08.018.
[13] Sugimoto M,Takagi T,Suzuki R,et al.Efficacy of steroid pulse therapy for autoimmune pancreatitis type 1: a retrospective study[J].PLoS One,2015,10(9):e0138604.DOI:10.1371/journal.pone.0138604.
[14] Khosroshahi A,Carruthers MN,Deshpande V,et al.Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients[J].Medicine(Baltimore),2012,91(1):57-66.DOI:10.1097/MD.0b013e3182431ef6.
[15] Carruthers MN,Topazian MD,Khosroshahi A,et al.Rituximab for IgG4-related disease: a prospective, open-label trial[J].Ann Rheum Dis,2015,74(6):1171-1177.DOI:10.1136/annrheumdis-2014-206605.